BridgeBio Oncology Therapeutics, Inc. (BBOT): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$4.30

Year ended 2025-12-31

2024-12-31 EPS (Diluted) (USD per share) 2025-12-31

Period ended	EPS (Diluted)	Change YoY	Source filing
2025-12-31	-$4.30	n/m	2026-03-05, From 2025-01-01
2024-12-31	-$5756.41	n/a	2026-03-05, From 2024-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Diluted)	Change YoY
BridgeBio Oncology Therapeutics, Inc. (BBOT)	2025-12-31	-$4.30	n/m
Biohaven Ltd. (BHVN)	2025-12-31	-$6.86	n/m
BGM Group Ltd. (BGM)	2025-09-30	-$0.18	n/m
Arcutis Biotherapeutics, Inc. (ARQT)	2025-12-31	-$0.13	n/m
Bicara Therapeutics Inc. (BCAX)	2025-12-31	-$2.52	n/m
MoonLake Immunotherapeutics (MLTX)	2025-12-31	-$3.53	n/m
Enliven Therapeutics, Inc. (ELVN)	2025-12-31	-$1.83	n/m
MapLight Therapeutics, Inc. (MPLT)	2025-12-31	-$18.56	n/m
Rhythm Pharmaceuticals, Inc. (RYTM)	2025-12-31	-$3.11	n/m

Compare BBOT, BHVN, BGM, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗